Senior Lecturer
- About
-
- Email Address
- i.n.fleming@abdn.ac.uk
- Telephone Number
- +44 (0)1224 438357
- Office Address
Aberdeen Biomedical Imaging Centre, Office 6.16, Institute of Medical Research, Foresterhill, Aberdeen AB25 2ZD, UK
- School/Department
- School of Medicine, Medical Sciences and Nutrition
- Research
-
Research Overview
Development of novel Positron Emission Tomography (PET) radiotracers to study the biological processes that are characteristic of tumour cells.
Development, validation and/or qualification of existing PET radiotracers so that they can be used as predictive, prognostic, pharmacological and/or surrogate response biomarkers in oncology patients.
Current Research
Current projects involve tracers to study cell proliferation, hypoxia and angiogenesis.
Collaborations
Prof Fiona Gilbert, University of Cambridge
Prof Paula Ghaneh, University of Liverpool
Prof David O'Hagan, University of St Andrews
Kemotech, Italy
Funding and Grants
Current Grants:
Validation of FLT-PET as a predictive biomarker in breast cancer (Cancer Research UK)
18F-fluoroazomycin-arabinofuranoside (FAZA) as a PET tracer in the detection of tumour hypoxia in patients with colorectal carcinoma: A pilot study (NHS Grampian Endowment)
Detection of hypoxia in breast cancer with Fluoroazomycin arabinoside (FAZA) analogues (Breast Cancer Campaign)
Studying the effect of different hypoxic subtypes on anti-cancer therapeutics in breast cancer cells (NHS Grampian Endowment)
Developing a novel αvβ3 radiotracer to report on tumour angiogenesis (Knowledge Exchange Transfer Fund)
Development of 18F-labelled PET tracer for preclinical HER2 imaging of gastroesophageal adenocarcinomas (NHS Grampian Endowment)
- Teaching
-
Teaching Responsibilities
Programme coordinator & lecturer BT3006: Working Out? Placement & Career skills
Programme coordinator BT5007: Industrial Placement/MSci course
Course coordinator & lecturer PA3802: Principles of Chemotherapy and mechanisms of disease
Course coordinator & lecturer BP5003: Biomedical and other Professional Topics
Lecturer SM2501: Research skills for Medical Sciences
Coordinator of Hotstart programme
- Publications
-
Page 3 of 6 Results 21 to 30 of 53
A localized tolerance in the substrate specificity of the fluorinase enzyme enables "last-step" 18F fluorination of a RGD peptide under ambient aqueous conditions
Angewandte Chemie International Edition, vol. 53, no. 34, pp. 8913-8918Contributions to Journals: Articles- [ONLINE] DOI: https://doi.org/10.1002/anie.201403345
- [ONLINE] View publication in Scopus
Early changes in [18F] FDG incorporation by breast cancer cells treated with trastuzumab in normoxic conditions: Role of the Akt-pathway, glucose transport and HIF-1α
Breast Cancer Research and Treatment, vol. 144, no. 4, pp. 241-248Contributions to Journals: ArticlesMultifunctional Deuterated and Tritiated “Click” Molecular Probes via Pd-mediated Reductive De-iodination of 5-Iodo-1,2,3-Triazoles
Synlett, vol. 25, no. 07, pp. 1019-1025Contributions to Journals: Articles- [ONLINE] DOI: https://doi.org/10.1055/s-0033-1340940
Tumour expression of leptin is associated with chemotherapy resistance and therapy-independent prognosis in gastro-oesophageal adenocarcinomas
British Journal of Cancer, vol. 110, no. 6, pp. 1525-1534Contributions to Journals: Articles- [ONLINE] DOI: https://doi.org/10.1038/bjc.2014.45
Hypoxia stimulates 18F-Fluorodeoxyglucose uptake in breast cancer cells via hypoxia inducible factor-1 and AMP-activated protein kinase
Nuclear Medicine and Biology, vol. 40, no. 6, pp. 858-864Contributions to Journals: Articles- [ONLINE] DOI: https://doi.org/10.1016/j.nucmedbio.2013.05.006
Efficient bioconjugation of 5-fluoro-5-deoxy-ribose (FDR) to RGD peptides for positron emission tomography (PET) imaging of αvβ3 integrin receptor
Organic & Biomolecular Chemistry, vol. 27, no. 11, pp. 4551-4558Contributions to Journals: Articles- [ONLINE] DOI: https://doi.org/10.1039/c3ob40550h
- [OPEN ACCESS] http://aura.abdn.ac.uk/bitstream/2164/4027/1/RGD_OBC_Template_for_AURA.docx
Response to trastuzumab by HER2 expressing breast tumour xenografts is accompanied by decreased Hexokinase II, glut1 and [18F]-FDG incorporation and changes in 31P-NMR detectable phosphomonesters
Cancer Chemotherapy and Pharmacology, vol. 71, no. 2, pp. 473-480Contributions to Journals: Articles- [ONLINE] DOI: https://doi.org/10.1007/s00280-012-2032-6
Positron emission tomography radiopharmaceutical studies in humans: a guide to regulations for academic researchers
Nuclear Medicine Communications, vol. 33, no. 9, pp. 899-906Contributions to Journals: Articles- [ONLINE] DOI: https://doi.org/10.1097/MNM.0b013e328356737f
Recommendations for measurement of tumour vascularity with positron emission tomography in early phase clinical trials
European Radiology, vol. 22, no. 7, pp. 1465-1478Contributions to Journals: Articles- [ONLINE] DOI: https://doi.org/10.1007/s00330-011-2311-3
Positron emission tomography oncology research in the UK: a comparison with USA and Europe
Nuclear Medicine Communications, vol. 33, no. 4, pp. 341-348Contributions to Journals: Articles- [ONLINE] DOI: https://doi.org/10.1097/MNM.0b013e3283500b6d